Table 1.
Characteristics of the COVID-19 patients contributing to this study.
| Death | Discharge | Total | |
|---|---|---|---|
| Sex | |||
| female | 4 (67%) | 15 (56%) | 19 (58%) |
| male | 2 (33%) | 12 (44%) | 14 (42%) |
| Age | |||
| median (IQR) | 89 (81, 94) | 69 (38, 91) | 77 (38, 94) |
| Comorbidities | |||
| hypertension | 4 (67%) | 18 (67%) | 22 (67%) |
| diabetes | 2 (33%) | 4 (15%) | 6 (18%) |
| COPD | 0 (0%) | 1 (4%) | 1 (3%) |
| CVD | 3 (50%) | 14 (52%) | 17 (52%) |
| cerebrovascular disease | 1 (17%) | 5 (19%) | 6 (18%) |
| adipositas | 1 (17%) | 6 (22%) | 7 (21%) |
| Time to discharge or death * [d] | |||
| median (IQR) | 10 (2, 32) | 19 (3, 46) | 15 (2, 46) |
* Death in combination with COVID-19 diagnosis, irrespective of final mortality cause.